These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 1696190)

  • 1. The frequency of Leu 1+B cells in autoantibody positive and negative autoimmune diseases and in neonatal cord blood.
    Kazbay K; Osterland CK
    Clin Exp Rheumatol; 1990; 8(3):231-5. PubMed ID: 1696190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD5+ B lymphocytes in systemic lupus erythematosus and rheumatoid arthritis.
    Smith HR; Olson RR
    J Rheumatol; 1990 Jun; 17(6):833-5. PubMed ID: 1696993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating anticentromere CENP-A and CENP-B antibodies in patients with diffuse and limited systemic sclerosis, systemic lupus erythematosus, and rheumatoid arthritis.
    Russo K; Hoch S; Dima C; Varga J; Teodorescu M
    J Rheumatol; 2000 Jan; 27(1):142-8. PubMed ID: 10648030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitation of autoantibody-secreting B cells in systemic lupus erythematosus.
    Ishigatsubo Y; Sakamoto H; Hagiwara E; Aoki A; Shirai A; Tani K; Okubo T; Klinman DM
    Autoimmunity; 1989; 5(1-2):71-8. PubMed ID: 2519019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-DNA antibody production by CD5+ and CD5- B cells of patients with systemic lupus erythematosus.
    Suzuki N; Sakane T; Engleman EG
    J Clin Invest; 1990 Jan; 85(1):238-47. PubMed ID: 1688569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monocyte cytotoxicity in connective tissue diseases. Correlation with disease groups.
    Thorsteinsson L; Abrahamsen TG; Frøland SS; Kåss OE
    Scand J Rheumatol; 1981; 10(1):49-54. PubMed ID: 6971489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of CD5 and CD23 on B cells of patients with rheumatoid arthritis, systemic lupus erythematosus and Sjögren's syndrome. Relationship with disease activity and treatment.
    Ebo D; DeClerck LS; Bridts CH; Stevens WJ
    In Vivo; 1994; 8(4):577-80. PubMed ID: 7534494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunohistochemical research in diffuse reactive mesenchymopathies. Results and interpretative speculations].
    Grimaldi MG
    Recenti Prog Med; 1969 Feb; 46(2):133-69. PubMed ID: 4893918
    [No Abstract]   [Full Text] [Related]  

  • 9. CD5 positive B lymphocytes in seronegative juvenile arthritis.
    Martini A; Massa M; De Benedetti F; Viola S; Neirotti G; Burgio RG
    J Rheumatol; 1990 Jul; 17(7):932-5. PubMed ID: 1698986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rheumatoid factor secretion from human Leu-1+ B cells.
    Hardy RR; Hayakawa K; Shimizu M; Yamasaki K; Kishimoto T
    Science; 1987 Apr; 236(4797):81-3. PubMed ID: 3105057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Anticardiolipin antibodies in autoimmune rheumatic diseases].
    Ergüven S; Calgüner M; Gülmezoğlu E; Sungur C; Ozcebe OI
    Mikrobiyol Bul; 1989 Jan; 23(1):1-11. PubMed ID: 2696861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitation of IgM- and IgG-secreting B cells in the peripheral blood of patients with systemic lupus erythematosus.
    Klinman DM; Shirai A; Ishigatsubo Y; Conover J; Steinberg AD
    Arthritis Rheum; 1991 Nov; 34(11):1404-10. PubMed ID: 1719987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Possible different mechanisms of B cell activation in systemic lupus erythematosus and rheumatoid arthritis: opposite expression of low-affinity receptors for IgE (CD23) on their peripheral B cells.
    Kumagai S; Ishida H; Iwai K; Tsubata T; Umehara H; Ozaki S; Suginoshita T; Araya S; Imura H
    Clin Exp Immunol; 1989 Dec; 78(3):348-53. PubMed ID: 2532990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A common anti-DNA idiotype and other autoantibodies in sera of offspring of mothers with systemic lupus erythematosus.
    el-Roeiy A; Gleicher N; Isenberg D; Kennedy RC; Shoenfeld Y
    Clin Exp Immunol; 1987 Jun; 68(3):528-34. PubMed ID: 3115649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antinuclear antibodies in systemic lupus erythematosus before and after treatment and in chronic progressive polyarthritis. Some observations on the antiperinuclear factor].
    Marmont A; Damasio E
    J Belge Rhumatol Med Phys; 1967; 22(4):236-66. PubMed ID: 4185874
    [No Abstract]   [Full Text] [Related]  

  • 16. Relationship between CD5+ B lymphocytes and the activity of systemic autoimmunity.
    Becker H; Weber C; Storch S; Federlin K
    Clin Immunol Immunopathol; 1990 Aug; 56(2):219-25. PubMed ID: 1696188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulatory effect of CD5 antibody on B cells from patients with rheumatoid arthritis.
    Hara M; Kitani A; Hirose T; Norioka K; Harigai M; Suzuki K; Tabata H; Kawakami M; Kawagoe M; Nakamura H
    Clin Immunol Immunopathol; 1988 Nov; 49(2):223-30. PubMed ID: 2458873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-13 in autoimmune rheumatic diseases: relationship with the autoantibody profile.
    Spadaro A; Rinaldi T; Riccieri V; Taccari E; Valesini G
    Clin Exp Rheumatol; 2002; 20(2):213-6. PubMed ID: 12051401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoantibodies and the autoimmune diseases.
    Josephson AS
    Bull N Y Acad Med; 1981 Sep; 57(7):631-7. PubMed ID: 6974027
    [No Abstract]   [Full Text] [Related]  

  • 20. High-affinity antibodies to ssDNA are produced by CD-B cells in systemic lupus erythematosus patients.
    Casali P; Burastero SE; Balow JE; Notkins AL
    J Immunol; 1989 Dec; 143(11):3476-83. PubMed ID: 2479680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.